# A Study of Severe Uterine Bleeding Following Exposure to Direct Oral Anticoagulants

> **NCT04394234** · — · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 961985 (actual)

## Conditions studied

- Uterine Hemorrhage

## Interventions

- **DRUG:** Direct oral anticoagulant (DOACs)
- **DRUG:** Warfarin

## Key facts

- **NCT ID:** NCT04394234
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-15
- **Primary completion:** 2020-06-01
- **Final completion:** 2020-06-01
- **Target enrollment:** 961985 (ACTUAL)
- **Last updated:** 2025-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04394234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04394234, "A Study of Severe Uterine Bleeding Following Exposure to Direct Oral Anticoagulants". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04394234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*